133 related articles for article (PubMed ID: 8588200)
1. Effects of low molecular weight heparin on a severely antithrombin III-decreased disseminated intravascular coagulation model in rabbits.
Tazawa S; Ichikawa K; Misawa K; Fukuyama J; Hamano S; Miyata H; Sakuragawa N
Thromb Res; 1995 Dec; 80(5):391-8. PubMed ID: 8588200
[TBL] [Abstract][Full Text] [Related]
2. [Effects of low molecular weight heparin (FR-860) on the experimental disseminated intravascular coagulation models].
Hamano S; Kinukawa M; Komatsu H; Miyata H; Sakuragawa N
Nihon Yakurigaku Zasshi; 1991 Jul; 98(1):53-62. PubMed ID: 1889762
[TBL] [Abstract][Full Text] [Related]
3. Effect of a synthetic thrombin inhibitor MCI-9038 on experimental models of disseminated intravascular coagulation in rabbits.
Hara H; Tamao Y; Kikumoto R; Okamoto S
Thromb Haemost; 1987 Apr; 57(2):165-70. PubMed ID: 3603410
[TBL] [Abstract][Full Text] [Related]
4. [Thrombin.antithrombin III complex].
Matsuo T; Kario K; Matsuo M
Rinsho Byori; 1991 Jul; 39(7):701-6. PubMed ID: 1920862
[TBL] [Abstract][Full Text] [Related]
5. Heparin cofactor II activity in patients with disseminated intravascular coagulation and hepatic failure.
Tollefsen DM; Pestka CA
Blood; 1985 Oct; 66(4):769-74. PubMed ID: 4041618
[TBL] [Abstract][Full Text] [Related]
6. Antithrombin III patterns in disseminated intravascular coagulation.
Bick RL; Bick MD; Fekete LF
Am J Clin Pathol; 1980 Apr; 73(4):577-83. PubMed ID: 7369182
[TBL] [Abstract][Full Text] [Related]
7. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
Gómez C; Páramo JA; Rocha E
Sangre (Barc); 1992 Feb; 37(1):5-10. PubMed ID: 1585238
[TBL] [Abstract][Full Text] [Related]
8. Effect of heparin, hirudin, and a synthetic thrombin inhibitor on antithrombin III in thrombin-induced disseminated intravascular coagulation in rats.
Hauptmann J; Brüggener E; Markwardt F
Haemostasis; 1987; 17(6):321-8. PubMed ID: 3428717
[TBL] [Abstract][Full Text] [Related]
9. Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin.
Sandler RM; Liebman HA; Patch MJ; Teitelbaum A; Levine AM; Feinstein DI
Cancer; 1982 Nov; 50(10):2106-10. PubMed ID: 6957257
[TBL] [Abstract][Full Text] [Related]
10. [Studies on antithrombin III. II. The role for antithrombin III (ATIII) in the control of disseminated intravascular coagulation (DIC). (The effect of the administration of ATIII concentrates in experimental DIC and in clinical DIC) (author's transl)].
Takahashi K
Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):889-97. PubMed ID: 6940410
[No Abstract] [Full Text] [Related]
11. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man.
Wolzt M; Weltermann A; Nieszpaur-Los M; Schneider B; Fassolt A; Lechner K; Eichler HG; Kyrle PA
Thromb Haemost; 1995 Mar; 73(3):439-43. PubMed ID: 7667826
[TBL] [Abstract][Full Text] [Related]
12. Effects of heparin oligosaccharides with high affinity for antithrombin III in experimental venous thrombosis.
Thomas DP; Merton RE; Barrowcliffe TW; Thunberg L; Lindahl U
Thromb Haemost; 1982 Jun; 47(3):244-8. PubMed ID: 7112499
[TBL] [Abstract][Full Text] [Related]
13. Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin.
Sandler RM; Liebman HA; Patch MJ; Teitelbaum A; Levine AM; Feinstein DI
Cancer; 1983 Feb; 51(4):681-5. PubMed ID: 6571800
[TBL] [Abstract][Full Text] [Related]
14. The course of disseminated intravascular coagulation is predicted by changes in thrombin-antithrombin III complex levels--is there any difference between treatment with standard heparin or low-molecular-weight heparin?
Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
Blood Coagul Fibrinolysis; 1991 Oct; 2(5):623-7. PubMed ID: 1664251
[TBL] [Abstract][Full Text] [Related]
15. Heparin treatment in thrombin-induced disseminated intravascular coagulation in the baboon.
du Toit HJ; Coetzee AR; Chalton DO
Crit Care Med; 1991 Sep; 19(9):1195-200. PubMed ID: 1884620
[TBL] [Abstract][Full Text] [Related]
16. Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo.
Eichinger S; Wolz M; Nieszpaur-Los M; Schneider B; Lechner K; Eichler HG; Kyrle PA
Thromb Haemost; 1994 Dec; 72(6):831-5. PubMed ID: 7740450
[TBL] [Abstract][Full Text] [Related]
17. Tissue thromboplastin induced reversible DIC and heparin-enhanced inhibitors in dogs.
Marbet GA; Griffith MJ
Thromb Haemost; 1986 Feb; 55(1):78-85. PubMed ID: 3518133
[TBL] [Abstract][Full Text] [Related]
18. Activity of antithrombin III and effect of heparin on coagulation in shock.
Blauhut B; Necek S; Kramar H; Vinazzer H; Bergmann H
Thromb Res; 1980 Sep; 19(6):775-82. PubMed ID: 7466746
[No Abstract] [Full Text] [Related]
19. Disseminated intravascular coagulation with multiple arterial thromboses responding to antithrombin-III concentrate infusion.
Wisecarver JL; Haire WD
Thromb Res; 1989 Jun; 54(6):709-17. PubMed ID: 2781511
[TBL] [Abstract][Full Text] [Related]
20. Treatment of DIC with antithrombin III concentrates.
Sakata Y; Yoshida N; Matsuda M; Aoki N
Bibl Haematol; 1983; (49):307-16. PubMed ID: 6667252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
